In memoriam · condoleanceregister
Zelig Eshhar
ook bekend als Zelig Eshhar
- Geboren
- 25 februari 1941
- Overleden
- 3 juli 2025
- Leeftijd
- 84 jaar
- Rustplaatsen
- Wetenschappers & uitvinders Bekende mensen, Israël Landen
Biografie
Zelig Eshhar (Hebrew: זליג אשחר; February 25, 1941 – July 3, 2025) was an Israeli immunologist at the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center. He was Chairman of the Department of Immunology at the Weizmann Institute twice, in the 1990s and 2000s.
Background
Zelig Lipka (later Eshhar) was born in Petah Tikva on February 25, 1941, and grew up in Rehovot. After his IDF service in Nahal, he joined Kibbutz Yad Mordechai, where he became a beekeeper. He received his B.Sc. and M.Sc. from the Hebrew University of Jerusalem, and his Ph.D. from the Weizmann Institute.
Eshhar died in Tel Yitzhak, Israel on July 3, 2025, at the age of 84.
Medical research
Eshhar is mainly known for his studies on T cells and his pioneering work on chimeric antigen receptors.
His work has been the basis of the development of a cancer immunotherapy, involving genetic modifications of T lymphocytes extracted from a cancer patient to produce chimeric antigen receptor (CAR) T-Cells, which are then injected back into the patient in a process called adoptive cell transfer, that produced startlingly good results in clinical trials in the mid-2010s and millions of dollars of investment.
Awards and recognition
In 2013 Eshhar was awarded the CAR Pioneering award by the ATTACK European Consortium as well as the European Society of Gene & Cell Therapy Outstanding Achievement Award. In 2014 he shared the Massry Prize with Steven Rosenberg and James P. Allison and the Pioneer Award with Carl H. June. He is the recipient of the 2015 Israel Prize in Life Sciences and the 2019 Cancer Research Institute's William B. Coley Award. In 2021 he was awarded the Dan David Prize. In 2024 he received the Canada Gairdner International Award. In December 2024, he also received the VinFuture Prize's Outstanding Achievements in Emerging Fields alongside Carl H. June and Michel Sadelain for their contributions to the development and advancement of CAR T cell therapy, a revolutionary "living drug" that is transforming the treatment of cancer and autoimmune diseases worldwide. In 2024 he was awarded the Warren Alpert Foundation Prize.
Bron: Wikipedia, beschikbaar onder de licentie CC BY-SA 4.0.
In Memoriam weblink
Medeleven en bloemen 0
Het condoleanceregister van Zelig Eshhar: betuig hieronder uw medeleven aan de nabestaanden, leg een bloem of steek een kaars aan.
- TroostplekSterkte aan alle nabestaanden.